Literature DB >> 26860987

Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.

Valeria Behle1, Marion Wobser2, Matthias Goebeler2, Johanna Stoevesandt2.   

Abstract

Fingolimod-related viral infections have been described on several occasions since its introduction in 2010. We hereby add a report on an otherwise immunocompetent, 18-year old Caucasian man with relapsing-remitting multiple sclerosis who developed a protracted and extensive molluscum contagiosum (MC) virus infection shortly after being started on fingolimod. Wide-spread cutaneous MC infections in adult patients are considered indicative of underlying immunosuppression. Neurologists prescribing fingolimod ought to be aware of a possibly increased risk of MC, but also need to know about its relative benignity, lack of extra-cutaneous complications, and adequate treatment options.
© The Author(s), 2016.

Entities:  

Keywords:  Fingolimod; immunosuppression; molluscum contagiosum; poxvirus

Mesh:

Substances:

Year:  2016        PMID: 26860987     DOI: 10.1177/1352458516629560

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  3 in total

Review 1.  ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).

Authors:  G Redelman-Sidi; O Michielin; C Cervera; C Ribi; J M Aguado; M Fernández-Ruiz; O Manuel
Journal:  Clin Microbiol Infect       Date:  2018-02-07       Impact factor: 8.067

2.  Disseminated molluscum contagiosum associated with immunomodulatory therapy.

Authors:  Megan Wetzel; W James Tidwell; Jeffrey P Callen
Journal:  JAAD Case Rep       Date:  2020-06-17

3.  Atypical molluscum contagiosum on multiple sclerosis patients treated with fingolimod: A case report.

Authors:  Hamed Cheraghmakani; Seyed Mohammad Baghbanian; Maryam Ghasemi
Journal:  Clin Case Rep       Date:  2022-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.